ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Teva-Takeda joint venture divests certain assets in Japan to Nichi-Iko
August 03, 2020A business joint venture (BV) comprising Teva Pharmaceutical and Takeda Pharmaceutical in Japan is set to divest the majority of its generic and operational assets to Nichi-Iko Pharmaceutical. -
Daiichi Sankyo to develop Nafamostat inhalation therapy for Covid-19
June 10, 2020Japanese pharmaceutical company Daiichi Sankyo has signed a basic agreement with the University of Tokyo, Nichi-Iko Pharmaceutical and RIKEN for the research and development (R&D) of a Nafamostat inhalation formulation to treat Covid-19.
Pharma Sources Insight January 2025
